NCT05393492

Brief Summary

After acquired brain injury (ABI), persons can experience emotional and behavioral difficulties, that can be painful both for the person and his/her family. This clinical study aims at measuring the effectiveness of a third wave cognitive behavioral therapy called "dialectical behavior therapy" (DBT). DBT aims at teaching persons emotion regulation skills, interpersonal effectiveness skills, mindfulness and distress tolerance skills through group and individual sessions. The study's hypothesis is that DBT, in an adapted format for persons with ABI can lead to

  • a better quality of life, emotional and behavioral regulation, and self-esteem
  • decrease in problematic behaviors
  • progress in life goals
  • increase post traumatic growth and spirituality
  • better family functioning and lesser burden for care givers
  • experiencing more emotions and more free will 45 persons with an ABI sustained more than 18 month back, will follow a 3 phases, follow-up with care as usual for 5 months, followed by 5 months of DBT, followed by 5 months of care as usual + DBT monthly sessions. Self- and family-questionnaire will explore quality of life, emotional regulation, self-esteem, stress, anxiety, cognitive difficulties, family functioning and coping, post traumatic growth and spirituality and will be compared across the 3 phases. Results will be analyzed at a group level but also at an individual level (each patient separately) to test for decrease in unwanted behaviors and at a dyadic level (the person and his/her spouse) to test for the mutual effect of regulating emotions. Persons' memories will by analyzed at 3 time points by a linguistic analysis, and experience of free will after ABI will be analyzed by transcribed narratives of participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

May 19, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2022

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

May 26, 2022

Status Verified

May 1, 2022

Enrollment Period

Same day

First QC Date

January 18, 2022

Last Update Submit

May 23, 2022

Conditions

Keywords

brain injurydialectical behavior therapyemotionsemotional dysregulationbehavioral disordersspiritualitychallenging behaviorslinguistic markersemotional distressfamily burdenfree willinterpretative phenomenological analysissingle-case experimental design

Outcome Measures

Primary Outcomes (1)

  • Quality Of Life after Brain Injury

    Evaluation of quality of life after brain injury with QOLIBRI (Quality Of Life after Brain Injury)on 37 items belonging to 6 factors: cognition, self, daily life and autonomy, social relationships, emotions and physical problems. The Qolibri scores are reported a 0-100. 0 is the worst and 100 is the best. Self-rated by GREMO patients.

    15 months

Secondary Outcomes (10)

  • Evaluation of the difficulties in emotions regulation

    15 months

  • Evaluation of self-esteem

    15 months

  • Evaluation of executive functioning

    15 months

  • Evaluation of reflective functioning

    15 months

  • Evaluation of psychological distress

    15 months

  • +5 more secondary outcomes

Study Arms (4)

GREMO patients

EXPERIMENTAL

1. 5 months of baseline : usual care of in a medico-social service (medical, social, neuropsychological and psychological), 2. 5 months of dialectical behavior therapy (DBT) -DBT skills training group : during 19 weeks 3. 5 months of follow-up : usual care of + monthly reminders of DBT intervention skills

Behavioral: Dialectical Behavior Therapy and Radically Open dialectical behavior therapy

Controls without brain injury

NO INTERVENTION

People without brain injury used as controls for linguistic markers of emotional expression regulation and free will.

GREMO patients' family

NO INTERVENTION

GREMO patients' relatives, without brain injury, living with the GREMO patient and ready to complete every day and adapted self-observational diary card similar to the one of the GREMO patient

Qualitative research ABI patients and families

NO INTERVENTION

Patients and relatives followed by the same medico-social service but not meeting GREMO patients eligibility criteria, participating only in the qualitative research on free will and spirituality

Interventions

Dialectical Behavior Therapy is a third wave cognitive-behavioral therapy. It focuses on emotional dysregulation and interactions between the patient and his family in genesis and maintenance of challenging behaviors. It is used here in an adapted form for cognitive problems. Delivered in a group format of 19 weeks + individual sessions.

GREMO patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons with acquired brain injury regardless of the type or location of the injury
  • Age between 18 and 68
  • Over 18 months since the acquired brain injury (or 6 month if mild traumatic brain injury)
  • Challenging behaviors or emotional dysregulation or high level of anxiety / depression or family's complaints about emotional dysregulation
  • Secondary or exacerbated by an acquired brain injury
  • Causing important suffering for themselves or their families
  • Being affiliated to a social security
  • Fluent in French
  • Being able to understand goals and risks and to give a dated and signed consent

You may not qualify if:

  • Clinically evident severe lack of insight, lack of abstract reasoning, or severe anosognosia
  • Patients without any complaints
  • Severe cognitive impairments, aphasia or intellectual impairments that doesn't allow to understand DBT skills, questionnaires or group intreactions
  • Non fluent in French
  • Associated brain degenerative disease
  • Cancerous brain injury with uncertain progression
  • Non-stabilized psychotic disorder
  • Following a third wave cognitive behavioral therapy during the research study (for example : acceptance and commitment therapy)
  • Controls without brain injury
  • Being 18 years old or more
  • Without brain injury
  • Non fluent in French
  • History of brain injury or brain disease
  • History of psychiatric disorder
  • Personality disorder
  • +21 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service EMOI-TC - Pôle de MPR Institut Universitaire de Réadaptation Clemenceau (IURC)

Illkirch-Graffenstaden, 67402, France

RECRUITING

MeSH Terms

Conditions

Brain InjuriesStrokeIschemiaBrain NeoplasmsEncephalitisHypoxia, BrainMeningitisMental Disorders

Interventions

Dialectical Behavior Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsNeuroinflammatory DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and Symptoms

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinded analysis of linguistic markers of emotional regulation and free will by an independent laboratory
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: DBT for patients
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2022

First Posted

May 26, 2022

Study Start

May 19, 2022

Primary Completion

May 19, 2022

Study Completion

December 1, 2025

Last Updated

May 26, 2022

Record last verified: 2022-05

Locations